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Abstract
Aims/hypothesis We assessed systemic and local muscle fuel
metabolism during aerobic exercise in patients with type 1
diabetes at euglycaemia and hyperglycaemia with identical
insulin levels.
Methods This was a single-blinded randomised crossover
study at a university diabetes unit in Switzerland. We studied
seven physically active men with type 1 diabetes (mean±SEM
age 33.5±2.4 years, diabetes duration 20.1±3.6 years, HbA1c
6.7±0.2% and peak oxygen uptake [V
:
O2peak] 50.3±4.5 ml
min−1 kg−1). Men were studied twice while cycling for
120 min at 55 to 60% of V
:
O2peak, with a blood glucose level
randomly set either at 5 or 11 mmol/l and identical
insulinaemia. The participants were blinded to the glycaemic
level; allocation concealment was by opaque, sealed enve-
lopes. Magnetic resonance spectroscopy was used to quantify
intramyocellular glycogen and lipids before and after exer-
cise. Indirect calorimetry and measurement of stable isotopes
and counter-regulatory hormones complemented the assess-
ment of local and systemic fuel metabolism.
Results The contribution of lipid oxidation to overall energy
metabolismwas higher in euglycaemia than in hyperglycaemia
(49.4±4.8 vs 30.6±4.2%; p<0.05). Carbohydrate oxidation
accounted for 48.2±4.7 and 66.6±4.2% of total energy
expenditure in euglycaemia and hyperglycaemia, respectively
(p<0.05). The level of intramyocellular glycogen before
exercise was higher in hyperglycaemia than in euglycaemia
(3.4±0.3 vs 2.7±0.2 arbitrary units [AU]; p<0.05). Absolute
glycogen consumption tended to be higher in hyperglycaemia
than in euglycaemia (1.3±0.3 vs 0.9±0.1 AU). Cortisol and
growth hormone increased more strongly in euglycaemia than
in hyperglycaemia (levels at the end of exercise 634±52 vs
501±32 nmol/l and 15.5±4.5 vs 7.4±2.0 ng/ml, respectively;
p<0.05).
Conclusions/interpretation Substrate oxidation in type 1 dia-
betic patients performing aerobic exercise in euglycaemia is
similar to that in healthy individuals revealing a shift towards
lipid oxidation during exercise. In hyperglycaemia fuel metab-
olism in these patients is dominated by carbohydrate oxidation.
Intramyocellular glycogen was not spared in hyperglycaemia.
Trial registration: ClinicalTrials.Gov NCT00325559
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Introduction
The performance of physical exercise imposes high demands
on patients with type 1 diabetes mellitus. Although recom-
mended by treatment guidelines [1], exercise may increase the
risk of hypoglycaemia [2–4] and bears the risk of deteriorat-
ing diabetes control due to complex interference with the
regulation of glucose transport into working muscle [5].
Detailed insight into the metabolic processes during
exercise in type 1 diabetic patients could refine treatment
recommendations during physical activity. However, quan-
titative data on fuel metabolism in exercising type 1
diabetic patients are scarce up to now. In clinical practice,
patients are advised to adapt insulin doses when planning to
perform exercise [1, 6]. The effects of differing levels of
insulin on substrate metabolism in exercising type 1
diabetic patients have recently been reported [7]. Converse-
ly, little is known on the complementary impact of differing
levels of blood glucose on fuel metabolism and exercise
performance in these patients. Recently, we found the
contribution of carbohydrate and lipid oxidation to overall
energy consumption to be similar in euglycaemia and
hyperglycaemia during exercise up to 40 min, but the study
design did not allow a detailed quantification of substrate
fluxes [8]. Even less is known on the effect of differing
glycaemic levels on fuel metabolism during aerobic
exercise of longer duration in patients with type 1 diabetes
mellitus. Studies in healthy individuals have consistently
shown that increased availability of carbohydrates before or
during exercise increased carbohydrate oxidation [9–13].
However, it is uncertain whether increased carbohydrate
availability also induces a saving of intramyocellular
glycogen during exercise [9, 14–20]. Interestingly, in
healthy individuals, hyperglycaemia is generally accom-
panied by physiological hyperinsulinaemia, thereby ham-
pering direct application of these findings to diabetic
patients.
The aim of the present study was to comprehensively
compare the local and systemic fuel metabolism of type 1
diabetic patients performing aerobic exercise under stable
euglycaemic and hyperglycaemic conditions at a similar
and comparably low insulinaemia. We hypothesised that:
(1) in euglycaemia, they would behave similarly to non-
diabetic individuals, shifting fuel oxidation towards con-
sumption of lipids in the course of exercise; (2) in
hyperglycaemia, they would show persistent oxidation of
carbohydrates; and (3) intramyocellular glycogen would be
spared in hyperglycaemia, but not in euglycaemia.
Methods
Patients, preliminary peak oxygen uptake testing We
recruited seven physically active male volunteers with type 1
diabetes mellitus for this study. Mean±SEM age and BMIwere
33.5±2.4 years and 24.3±0.4 kg/m2. Average duration of
physical exercise was 255±65 min per week. Diabetes
duration was 20.1±3.6 years, and all volunteers had
continuous subcutaneous insulin infusion, with a mean
insulin dose of 0.61±0.05 U kg−1 day−1. HbA1c was 6.7±
0.2%. Informed written consent was obtained and the study
was approved by the local Ethics Committee. Peak oxygen
uptake (V
:
O2peak) was determined during a stepwise incre-
mental test on a bicycle ergometer with breath-to-breath
spirometry (Cardiovit AT-104PC; Schiller, Baar, Switzer-
land). The criteria used for attainment of V
:
O2peak were as
follows: a heart rate >90% of predicted value, inability to
pedal at a rate of 60 rev/min, a near maximal rate of
perceived exertion (RPE) ≥19 [21] and a respiratory
exchange ratio >1.10. Mean V
:
O2peak was 50.3±4.5 ml
min−1 kg−1.
Study design This was a randomised, single-blinded, cross-
over trial. Each participant was investigated twice at an
interval of 7 weeks (range 6–10). Patients were blinded to
glycaemia, randomly set to either euglycaemia or hyper-
glycaemia. Randomisation was by sealed opaque envelopes.
Prior to the first test, participants were familiarised with the
study procedures including a full ride over 120 min. The
experimental plan of the main test is outlined in Fig. 1.
Pre-test standardisation procedures and overnight prepara-
tion phase Prior to the main test, patients followed an
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isoenergetic diet (145–165 kJ/kg body weight; 60%
carbohydrate, 20% protein, 20% fat). Strenuous exercise
was not allowed for 72 h and the patients refrained from
alcohol for 48 h before the main test. Patients arrived at the
hospital the night before the main experiment and stayed
overnight. At 20:00 hours they were offered a standardised
meal corresponding to 35% of their expected basal energy
requirements (60% carbohydrate, 20% fat and 20% protein).
Continuous subcutaneous insulin infusion was disconnected
at 21:00 and an indwelling 18G cannula was inserted into
one vein of each forearm, for sampling and administration of
insulin, glucose and tracer, respectively. Overnight, glucose
concentrations were maintained within the 4–7 mmol/l range
with variable infusion of regular insulin (Actrapid; Novo
Industries, Copenhagen, Denmark). Patients were then kept
fasting but had free access to sugar-free water until the end of
the study on the following day.
Exercise test and spirometry The exercise consisted of
120 min (start=t0) cycling at a power corresponding to 55–
60% V
:
O2peak. Spirometry was performed from t−10 to t15, t50
to t70 and t100 to t120. Urinary urea and glucose concen-
trations were analysed before and during exercise to quantify
nitrogen excretion [22] and glucose spill-over. Rates of
substrate oxidation were then calculated using standard
equations [23, 24]. ECG was monitored continuously, blood
pressure was regularly measured and RPE was assessed by
the Borg scale every 10 min.
Euglycaemic and hyperglycaemic clamp procedures For the
clamp the insulin infusionwas fixed at a rate (median 7mUm−2
min−1, range 5–8.2 mU m−2 min−1) corresponding to the
individual reduced basal rate commonly applied during a
similar exercise. Euglycaemia (target level 5 mmol/l) or
hyperglycaemia (target level 11 mmol/l) were maintained by
infusion of 20% dextrose [25]. Blood glucose was measured
every 5 min and glucose infusion was adapted accordingly.
When stable glycaemia was reached, infusions of stable
isotopic tracers were started: D-[U-13C]glucose was infused
at a rate of 1.25 μg kg−1 min−1 (primed with 25 μg kg−1
[mmol/l glucose]−1). D-[6–6–2H2]Glucose was infused at a
rate of 30 μg kg−1 min−1 (primed with 0.6 mg kg−1 [mmol/
l glucose]−1). The bicarbonate pool was simultaneously
primed with 6 μmol/kg NaH13CO3. During exercise the
infusion rates were quadrupled in order to minimise changes
in enrichment [26]. Isotopes were manufactured by Cam-
bridge Isotope Laboratories, Innerberg, Switzerland. Sterile
pathogen-free solutions were prepared by the University
Hospital Pharmacy, Lausanne, Switzerland.
Samples and biochemical analysis Blood glucose and
lactate were measured every 5 min by an immobilised
glucose-oxidase and lactate-oxidase method (YSI2300;
Yellow Springs Instruments, Yellow Springs, OH, USA)
and are presented in 15 min intervals. Serum insulin and
NEFA were sampled twice before exercise and every
15 min during exercise. NEFA were determined using a
commercially available kit (Wako Pure Chemical, VWR
International, Dietikon, Switzerland). Counter-regulatory
hormones were sampled twice before exercise and twice
during the last 10 min of the exercise. They are reported as
mean pre- and post-test values. Catecholamine levels were
determined by high-performance liquid chromatography
(PU-980; Jasco, Tokyo, Japan) coupled to an electrochem-
ical detector (CLC 100; Chromosystems, Munich, Germany).
Growth hormone was measured using a chemiluminescence
method (Immulite One; DPC, Los Angeles, CA, USA).
Glucagon was measured using a double radioimmuno-
assay (Siemens Medical Solutions Diagnostic, Los Angeles,
CA, USA) in EDTA plasma mixed with aprotinin, immedi-
ately cooled and frozen after separation. Cortisol and insulin
were measured with electro-chemiluminescence immuno-
assays (Roche Modular-E170; Roche Diagnostics, Rotkreuz,
Switzerland).
Tracer samples and glucose turnover Double background
enrichment measurements (blood and breath samples) were
taken prior to infusion at 07:00 hours (t−180). After a
160 min equilibration phase to reach steady-state tracer
enrichments, two blood and breath samples were obtained
before exercise (t−20 and t−10). Blood samples were
obtained during exercise at t90, t100, t110 and t120. Breath
samples were obtained at t90 and t120 and collected in
vitreous tubes. Isotopic enrichments of D-[6-6-2H2]glucose
were determined by gas-chromatography mass-spectrome-
try (GC 5890/MS 5971; Hewlett-Packard, Palo Alto, CA,
USA). Isotopic enrichment of 13CO2 and
13C glucose was
measured by isotope ratio mass spectrometry (Tracermass
13C/15N; Europa Scientific, Crewe, UK). At rest glucose
rate of appearance (Ra) and rate of disappearance (Rd) were
calculated from D-[6-6-2H2]glucose enrichments using
Steele’s equations [26]. During exercise non-steady state
conditions were presumed and Ra and Rd were calculated
using the modified Steele equations for non-steady state
conditions [26] assuming an effective fraction of 0.65 and a
distribution volume of 0.22 l/kg. The oxidation rate of
07:00
(t
–180)
Exercise 
120 min MRS 2MRS 1
Overnight 
euglycaemia
08:15 10:00
(t0)
12:00
(t120)
Transfer 
and start 
clamp
Time of day 
(hours)
Clamp procedure
Fig. 1 Experimental plan. Timepoint 0 (t0) denotes start of exercise.
Dashed line, duration of euglycaemic or hyperglycaemic clamp procedure
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systemic glucose was calculated from labelled 13CO2 and
labelled D-[U-13C]glucose, using a recovery factor of 0.8
during rest and 1.0 during the exercise [27]. Endogenous
glucose production was calculated from the infusion rate and
the total Ra. Glucose disposal was calculated by taking into
account the urinary glucose loss. The difference between net
carbohydrate oxidation and the oxidation of systemic
glucose was used to calculate glycogen breakdown rates.
Magnetic resonance spectroscopy Muscular glycogen [28]
and intramyocellular lipids (IMCL) [29] were measured
sequentially in the right m. quadriceps by 13C and 1H-
magnetic resonance spectroscopy (MRS) before and after
exercise on both test occasions (total four measurements per
participant). Mean±SEM interval between start of the
clamp and start of the MRS was 55±7 min. The right leg
was placed in a specially designed cast to guarantee a
reproducible position of the muscle within the magnetic
field. Positioning at initial measurement and repositioning
(the following three measurements) of the 1H/13C-coil as
well as of the 1H-voxel was monitored by two series of
localiser images. The total time for one combined mea-
surement of glycogen and IMCL was 95 min. All MRS
examinations were performed on a clinical 1.5 T whole-
body scanner (SIGNA, General Electric, Milwaukee, WI,
USA) equipped with a 13C/1H double-tuned flexible coil
(1H: Helmholtz design, 13C: single turn 11.5×11.5 cm2,
Medical Advance, Milwaukee, WI, USA).
For 1H-MRS, IMCL was measured in an 11×12×18 mm3
(in right/left×anterior/posterior×inferior/superior directions)
sized voxel in m. vastus intermedius using an optimised
short echo time point resolved spectroscopy (PRESS)
sequence (repetition time TR=3 s, echo time TE=20 ms,
2,000 Hz, 1,024 pts, 128 acquisitions, water presaturation
and outer volume suppression) and quantified using the
unsuppressed fully relaxed water signal as internal concen-
tration standard. IMCL concentrations in absolute units of
mmol per kg muscle wet weight (mmol/kgww) were
calculated as reported earlier [30]. A reproducibility study
revealed a typical CVof 6% for repeated measurements [29]
of IMCL.
For 13C-MRS, glycogen and creatine content were
measured by 13C-MRS using a pulse-and-acquire sequence
(adiabatic 90° excitation, repetition time TR=165 ms,
5,000 Hz, 512 pts, 12,000 acquisitions per measurement).
1H decoupling during data acquisition and nuclear Over-
hauser effect build-up between the acquisitions were done
using a partially home-built second channel. Absolute
glycogen concentrations were normalised to the creatine
signal and expressed in arbitrary units (AU). Relative
glycogen changes denote percentage changes during exer-
cise. Signals of glycogen and creatine were evaluated using
the jMRUI software package (version 3.0, Magnetic Reso-
nance User Interface, University of Barcelona, Spain) as
described in detail in [31].
Statistical analysis Values are expressed as mean±SEM.
Non-normally distributed data were log-transformed. Paired
data were compared using Student’s t test. For parameters
with repeated measurements, AUCs were calculated. All
analyses were performed using Stata version 9.2 (Stata
Corporation, College Station, TX, USA).
Results
Euglycaemic and hyperglycaemic clamp procedures Insulin
levels did not differ between euglycaemia and hyper-
glycaemia, with mean levels during exercise at 121.5±
21.5 and 123.6±22.2 pmol/l respectively (Fig. 2a). Mean
blood glucose during exercise was 5.4±0.5 mmol/l for
euglycaemia and 11.0±0.3 mmol/l for hyperglycaemia (p<
0.001) (Fig. 2b). The total amount of infused glucose was
higher for hyperglycaemia than for euglycaemia (733±182
and 283±89 mg/kg; p<0.05).
Exercise levels Mean exercise levels were similar in
euglycaemia and hyperglycaemia (57.0±1.4 and 56.6±
0
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1.2% of predetermined V
:
O2peak, respectively). There was
an identical increase in RPE from baseline throughout the
exercise in euglycaemia and in hyperglycaemic exercise
conditions. Values at the end of exercise were 16.1±0.8 in
euglycaemia and 15.6±0.9 in hyperglycaemia. Lactate
levels were similar in euglycaemia and hyperglycaemia,
starting at 0.6±0.1 and 0.7±0.1 mmol/l at baseline and
increasing to a maximum of 1.3±0.3 and 1.4±0.3 mmol/
l respectively after 30 min. Thereafter, lactate levels
declined in both groups, levels being lower in euglycaemia
than in hyperglycaemia during the second hour of exercise
(p<0.05 for AUC).
Spirometry and net carbohydrate and lipid oxidation
rates Table 1 sums up the respiratory gas exchange at rest
and during exercise. There were no baseline differences in
V
:
O2 and CO2 production (V
:
CO2) between euglycaemia and
hyperglycaemia. The increase of V
:
O2 during exercise was
more pronounced in euglycaemia than in hyperglycaemia,
resulting in a higher level of V
:
O2 at the end of exercise in
the former condition (29.7±2.1 vs 28.4±2.0 ml min−1 kg−1,
p<0.05). Values for V
:
CO2 were similar in euglycaemia and
hyperglycaemia throughout the entire exercise. This translat-
ed into a higher respiratory exchange ratio during exercise in
hyperglycaemia than in euglycaemia (0.89±0.01 vs 0.84±
0.01 at the end of exercise; p<0.05). The contribution of net
carbohydrate oxidation to overall substrate oxidation was
higher in hyperglycaemia than in euglycaemia (66.6±4.2 vs
48.2±4.7% at the end of exercise; p<0.05). Inverse findings
resulted for the contribution of net lipid oxidation to overall
substrate oxidation, which was higher in euglycaemia than in
hyperglycaemia (49.4±4.8 vs 30.6±4.2%; p<0.05).
Local and systemic carbohydrate metabolism During the
first 30 min of exercise, glucose infusion rates were low in
euglycaemia and hyperglycaemia (0.3±0.2 and 1.8±1.0 mg
min−1 kg−1). Rates increased throughout exercise to 4.4±1.2
and 9.5±1.5 mg min−1 kg−1 during the last 30 min in
euglycaemia and hyperglycaemia (p<0.01). Table 2 shows
the parameters of glucose turnover assessed by stable isotope
technique. Endogenous glucose production was at similarly
low levels at rest in euglycaemia and hyperglycaemia (2.4±
0.2 and 1.9±0.6 mg min−1 kg−1). In euglycaemia endoge-
nous glucose production significantly increased during
exercise (to 4.0±0.6 mg min−1 kg−1 during the last 30 min;
p<0.05 compared with rest), but remained stable in hyper-
glycaemia (1.9±0.8; p<0.01 for difference to euglycaemia).
Conversely, glucose disposal tended to be higher during
exercise in hyperglycaemia than in euglycaemia (11.3±1.6
vs 8.4±0.8 mg min−1 kg−1 for last 30 min). The oxidation
rate of systemic glucose corresponded well to the glucose
disposal and tended to be higher in hyperglycaemia than in
euglycaemia towards the end of exercise (10.3±1.3 vs 8.4±
1.1 mg min−1 kg−1).
The calculated glycogen breakdown rates at the end of
exercise were lower in euglycaemia than in hyperglycaemia
(9.3±2.4 and 13.2±1.8 mg min−1 kg−1; p<0.05). The
corresponding results from MRS are shown in Fig. 3a, where
absolute levels of glycogen before exercise are seen to be
Table 1 Respiratory gas exchange and net substrate oxidation rates
Parameter Rest Exercise
60 min 120 min
V
:
O2 (ml min
−1 kg−1)
Euglycaemia 4.4±0.8 28.6±2.4c 29.7±2.1c,d
Hyperglycaemia 5.0±0.2 28.2±2.0c 28.4±2.0a,c
V
:
CO2 (ml min
−1 kg−1)
Euglycaemia 3.4±0.6 24.5±2.0c 24.9±1.9c
Hyperglycaemia 3.9±0.2 25.0±1.7c 25.4±1.8c
Carbohydrate oxidation (mg min−1 kg−1)
Euglycaemia 1.2±0.4 19.1±2.0c 17.5±2.5c
Hyperglycaemia 1.0±0.4 22.6±2.1c 23.7±2.1a,c
Lipid oxidation (mg min−1 kg−1)
Euglycaemia 1.6±0.4 6.6±0.8c 7.7±0.8c,d
Hyperglycaemia 1.7±0.2 5.1±0.9b 4.8±0.8a,b
Data are mean±SEM (n=7)
Data are reported as mean over 5 min at rest and mean over each
15 min from t55 to t70 and from t105 to t120
a p<0.05 for hyperglycaemia compared with euglycaemia; b p<0.01
compared with the corresponding baseline value; c p<0.001 compared
with the corresponding baseline value; d p<0.05 compared with the
corresponding value at 60 min
Table 2 Glucose turnover
Parameter Rest Exercise
Endogenous glucose production (mg min−1 kg−1)
Euglycaemia 2.4±0.2 4.0±0.6c
Hyperglycaemia 1.9±0.6 1.9±0.8b
Glucose disposal (mg min−1 kg−1)
Euglycaemia 2.6±0.1 8.4±0.8e
Hyperglycaemia 2.9±0.3 11.3±1.6d
Oxidation rate of systemic glucose (mg min−1 kg−1)
Euglycaemia 1.9±0.3 8.4±1.1
Hyperglycaemia 1.6±0.1 10.3±1.3e
Glycogen breakdown rate (mg min−1 kg−1)
Euglycaemia −0.8±0.6 9.3±2.4d
Hyperglycaemia −0.6±0.4 13.2±1.8a,e
Data are mean±SEM (n=7); data at rest are mean of two measurements
and during exercise mean of four measurements during the last 30 min
Rate of appearance and disappearance were derived from D-[6-6-2H2]
glucose enrichment and oxidation rate of systemic glucose from
13CO2 and D-[U-
13C]glucose
a p<0.05 for hyperglycaemia compared with euglycaemia; b p<0.01
for hyperglycaemia compared with euglycaemia; c p<0.05 compared
with the corresponding baseline values; d p<0.01 compared with the
corresponding baseline values; e p<0.001 compared with the
corresponding baseline values
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higher in hyperglycaemia than in euglycaemia (3.4±0.3 vs
2.7±0.2 AU; p<0.05). Absolute glycogen consumption
tended to be higher in hyperglycaemia than in euglycaemia
(1.3±0.3 vs 0.9±0.1 AU) while relative proportions were
comparable for both glycaemic levels (35.2±6.5 and 31.2±
3.5%).
Local and systemic lipid metabolism As shown in Table 1,
the increase of the net lipid oxidation rate was more
pronounced in euglycaemia than in hyperglycaemia (7.7±
0.8 vs 4.8±0.8 mg min−1 kg−1 at the end of exercise; p<
0.05). Levels of NEFA during exercise tended to be higher in
euglycaemia than in hyperglycaemia (0.63±0.07 vs 0.56±
0.05 mmol/l). Baseline levels of IMCL assessed by MRS
were comparable in both conditions (euglycaemia 6.4±0.7
vs 6.3±0.6 mmol/kg muscle wet weight; Fig. 3b). The
relative and absolute amounts of IMCL consumed during
exercise tended to be higher in euglycaemic than in hyper-
glycaemic conditions (−1.1±0.2 and −0.7±0.4 mmol/kg
muscle wet weight and −16.2±2.6 and −11.5±4.9%).
Summary of energy consumption Figure 4 summarises the
relative contribution of local and systemic fuel sources to
overall energy metabolism. In euglycaemia, 49.4±4.8% of the
total energy demands was met by lipid oxidation, while
carbohydrate oxidation accounted for 48.2±4.7%. About half
of carbohydrate oxidation (24.2±6.0%) was from oxidised
intramyocellular glycogen, the other half was accounted for by
systemic glucose (11.9±2.2% by endogenous hepatic glucose
production, 12.2±3.4% by exogenous glucose infusion). In
hyperglycaemia, the contribution of lipid oxidation to overall
energy consumption was lower than in euglycaemia (30.6±
4.2%; p<0.05). Conversely, significantly more energy was
provided by carbohydrate oxidation in hyperglycaemia than in
euglycaemia (66.6±4.2%; p<0.05). In hyperglycaemia, oxi-
dation from systemically available glucose was mainly fed by
exogenous glucose infusion (25.6±5.1%), while endogenous
hepatic glucose production was significantly lower than in
euglycaemia (4.2±1.7%; p<0.01). Protein oxidation was
similarly low in both conditions (euglycaemia 2.4±0.2 vs
2.8±0.3%).
Hormonal regulation Figure 5 depicts the levels of counter-
regulatory hormones before and at the end of exercise.
While levels for cortisol (Fig. 5a) were not different at
baseline in either condition (euglycaemia 449±55 vs 501±
73 nmol/l), there was a significant increase during
euglycaemia but not in hyperglycaemia (levels at the end
of exercise 634±52 vs 501±32 nmol/l; p<0.05). Similarly,
levels of growth hormone (Fig. 5b) were comparable before
exercise in both conditions (euglycaemia 2.6±1.2 vs 3.3±
2.1 μg/l). During exercise there was a stronger increase in
growth hormone in euglycaemic than in hyperglycaemic
exercise conditions, resulting in significantly higher levels
at the end of exercise in the former (euglycaemia 15.5±4.5
vs 7.4±2.0 μg/l; p<0.05). Levels of norepinephrine and
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epinephrine (Fig. 5c,d) were similar at baseline and
increased moderately and to a similar extent in euglycaemia
and hyperglycaemia. Similarly, levels of glucagon (Fig. 5e)
were not different between the two conditions either before
or at the end of exercise.
Discussion
This is the first study to assess the impact of differing glucose
levels at similar and comparably low insulinaemia on fuel
metabolism during aerobic exercise in patients with type 1
diabetes mellitus. The principal findings were that: (1) during
exercise the rate of carbohydrate oxidation was higher in
hyperglycaemia than in euglycaemia; conversely, the rate of
lipid oxidation was higher in the latter; (2) intramyocellular
glycogen was not spared in hyperglycaemia and glycogen
breakdown was even increased in this condition compared
with euglycaemia; and (3) in the presence of identical insulin
concentrations hyperglycaemia rapidly increased pre-exercise
intramuscular glycogen.
This confirms our hypothesis of a shift from carbohy-
drate oxidation towards a predominance of lipid oxidation
in the course of aerobic exercise in euglycaemia but not in
hyperglycaemia, if insulin infusion is adapted in patients
with type 1 diabetes mellitus. The relative contributions of
carbohydrate and lipid oxidation to overall energy produc-
tion found in the present study in euglycaemia were
virtually identical to those reported in the study of Hawley
and colleagues in healthy athletes exercising in euglycaemia
and hyperglycaemia [12]. In the present study the relative
contributions in euglycaemia were 49%, 24% and 24% for
lipids, systemic glucose and local glycogen, while their
values in euglycaemia were 53%, 26% and 21%. It can,
consequently, be stated that patients with type 1 diabetes
mellitus performing aerobic exercise in euglycaemia behave
metabolically in a similar way to healthy individuals.
The underlying mechanisms for these findings are not
entirely known. During moderate exercise (<60% of
V
:
O2peak) the ratio of glucagon to insulin is the main
regulator of fuel metabolism in healthy individuals [32]. In
the present study both insulin and glucagon were not
different in euglycaemia and hyperglycaemia and are,
therefore, unlikely to have caused the shift in fuel
oxidation. Similarly, the levels of catecholamines were
virtually identical in both glycaemia conditions. In contrast,
differences were observed for cortisol and growth hormone.
Thus while baseline levels of cortisol were identical in
euglycaemia and hyperglycaemia, they increased during
exercise in euglycaemia, but not in hyperglycaemia.
Comparably, the levels of growth hormone, also similar at
baseline, increased to a greater extent during euglycaemia
compared with hyperglycaemia. Both hormones are known
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to induce peripheral lipolysis [33] and could have played a
role in the shift towards higher lipid oxidation in euglycae-
mia compared with hyperglycaemia. This hypothesis is
further substantiated by the tendency towards higher levels
of NEFA in euglycaemia than in hyperglycaemia, reflecting
an increased peripheral lipolysis.
Data on intramyocellular glycogen and lipids in general
are scarce for patients with type 1 diabetes mellitus. In the
present study, the pre-exercise concentration of IMCL and
its consumption during exercise in euglycaemia were
comparable to concentrations assessed by similar tech-
niques in healthy athletes [31], the consumption of IMCL in
hyperglycaemia being slightly lower. Interestingly, the
results of the present study did not confirm our hypothesis
regarding a saving of intramyocellular glycogen during
hyperglycaemia compared with euglycaemia. The mecha-
nisms by which hyperglycaemia increased glycogen con-
sumption are not fully understood. Interestingly, the
capacity of glycogen storage has been reported to be
impaired in type 1 diabetes mellitus [34]. While the
absolute amount of pre-exercise glycogen in hyperglycae-
mia in the present study was similar to levels found in
healthy athletes [31, 35], pre-exercise glycogen concen-
trations were considerably lower in euglycaemia. Studies in
healthy individuals have shown that net muscle glycogen
utilisation is determined by muscle glycogen content before
exercise [35]. It is a matter of debate whether this is a pure
mass action effect initiated by the readily available fuel in
the muscle cell, as was suggested by a genetically modified
mouse model overaccumulating glycogen due to over-
expression of glycogen synthase [36]. Other studies have
suggested a cross-talk hypothesis through an upregulation
of glycogen phosphorylase in the presence of higher
glycogen stores [37]. Due to the pre-test standardisation
procedures of the present study, including similar diet and
physical activity before both tests, it is unlikely that the
increased glycogen levels before exercise in hyperglycae-
mia were due to a systematically higher intake of
carbohydrates in the days before. Conversely, it is conceiv-
able that the hyperglycaemic clamp procedure, started just
under 1 h before the pre-test MRS, induced a rapid
synthesis of intramyocellular glycogen. The similar esti-
mated rates of glycogen synthesis using the stable isotope
data before exercise do not necessarily argue against this
hypothesis, since it is unknown whether glycogen synthesis
is a linear process and it is possible that synthesis was
mainly activated in the early stage of the hyperglycaemic
clamp. In agreement with this hypothesis, it has been
shown previously that a single high-carbohydrate meal
taken 4 h before exercise may increase glycogen content in
M. vastus by over 40% [9].
The present study provides a complementary approach to
the recent study of Chokkalingam and colleagues [7].
While they assessed the influence of differing insulin
concentrations in euglycaemia on whole-body and muscle
metabolism, the present study investigated the impact of
dissimilar glucose concentrations at stable and comparably
low insulinaemia on fuel metabolism during exercise. They
reported an increase in exogenous glucose utilisation in
hyperinsulinaemia, without concomitant sparing of muscle
glycogen utilisation, which is consistent with the present
results. The longer exercise duration of the present study
allowed us to observe changes in aerobic substrate
metabolism over an extended follow-up. In addition, insulin
concentrations in the present study were lower than both
insulin levels in Chokkalingam’s trial in order to reflect
insulin dose reductions before and during exercise as
recommended by treatment guidelines [1].
The strengths of the present study are its standardised
and randomised design, combining techniques to quantify
glucose turnover by stable isotope tracer technique with
non-invasive methods to quantify IMCL and glycogen.
Glycogen measurements derived from indirect calculations
were consistent with the results from MRS. We neverthe-
less acknowledge several limitations: First, the complex
study design limited the number of participants. Second,
our insight into lipid metabolism did not encompass
turnover quantification using tracer technique. We agreed
to this compromise in order to keep the technical
interventions manageable and thereby ensure the quality
of the performed measurements. Third, due to technical
reasons (duration of exercise, magnetic field) no heating
box could be used for the clamp. Importantly, previous
studies have confirmed sufficient arterialisation of ante-
cubital venous blood during exercise of similar duration
and intensity [12]. Fourth, the maintenance of hyper-
glycaemia by continuous glucose infusion was an artificial
intervention, limiting the direct applicability of our findings
to daily clinical practice. Conversely, a deeper insight into
the metabolic processes during exercise in type 1 diabetes
mellitus patients under controlled conditions may still be a
step towards the refinement of treatment guidelines for
these patients.
In conclusion, the results of the present study suggest
that substrate oxidation in type 1 diabetic patients
performing aerobic exercise in euglycaemia is comparable
to that observed in healthy individuals, revealing a shift
towards lipid oxidation in the course of exercise. In
contrast, exercising in hyperglycaemia retains fuel metab-
olism in an artificially restrained state of carbohydrate
predominance. No evidence was found for a saving of
intramyocellular glycogen in hyperglycaemia. Further stud-
ies investigating fuel metabolism during exercise in patients
with type 1 diabetes mellitus should now focus on the
intracellular mechanisms involved in the regulation of
substrate oxidation in different glycaemic states.
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